Cerebral Palsy clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 2-8
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.
San Francisco, California and other locations
Our lead scientists for Cerebral Palsy research studies include Hannah C. Glass, MDCM, MAS.